share_log

Cantor Fitzgerald Reiterates Overweight on Actinium Pharma, Maintains $21 Price Target

Moomoo 24/7 ·  Apr 1 08:24

Cantor Fitzgerald analyst Kristen Kluska reiterates Actinium Pharma (AMEX:ATNM) with a Overweight and maintains $21 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment